Gene: ANO10
Official Full Name: anoctamin 10provided by HGNC
Gene Summary: The transmembrane protein encoded by this gene belongs to the anoctamin family of calcium-activated chloride channels, also known as the transmembrane 16 family. The encoded protein contains eight transmembrane domains with cytosolic N- and C-termini. Defects in this gene may cause autosomal recessive spinocerebellar ataxia-10. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2016]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO19792 | ANO10 Knockout cell line (HeLa) | Human | ANO10 | 1:3~1:6 | Negative | Online Inquiry |
KO19793 | ANO10 Knockout cell line (HCT 116) | Human | ANO10 | 1:2~1:4 | Negative | Online Inquiry |
KO19794 | ANO10 Knockout cell line (HEK293) | Human | ANO10 | 1:3~1:6 | Negative | Online Inquiry |
KO19795 | ANO10 Knockout cell line (A549) | Human | ANO10 | 1:3~1:4 | Negative | Online Inquiry |
ANO10 Gene Knockout Cell Lines are genetically engineered mammalian cell models designed to specifically disrupt the ANO10 gene, which encodes an important calcium-activated chloride channel. This innovative product typically operates through CRISPR/Cas9 technology, where precise genome editing leads to a complete knockout of the ANO10 gene expression. The loss of ANO10 function creates a valuable tool for researchers investigating its role in various physiological and pathological processes, including hearing loss and cancer.
The key mechanism of these knockout cell lines involves a targeted delivery system that relies on the efficient and accurate introduction of Cas9 and guide RNA into cells, resulting in the specific excision of the ANO10 gene. This manipulation not only allows for the study of channel-specific functions but also aids in elucidating downstream signaling pathways that may be affected by the loss of ANO10. Such insights are critical for understanding its biological significance and potential therapeutic targets.
From a scientific perspective, ANO10 Gene Knockout Cell Lines hold substantial importance in both research and clinical settings. They provide a reliable platform for studying the underlying mechanisms of diseases linked to ANO10 dysfunction and can serve as preclinical models for therapeutic testing, enabling the development of targeted interventions.
Compared to conventional cell lines or models, these knockout lines offer distinct advantages, including a defined genetic modification that allows for unambiguous interpretation of results. While alternatives might involve the use of pharmacological inhibitors or siRNA, which can produce off-target effects, the ANO10 Gene Knockout Cell Lines provide clear and robust data aligned with specific genetic perturbations.
This product is valuable for researchers and clinicians striving to advance their understanding of cellular mechanisms and therapeutic strategies related to ion channel function. By utilizing these cell lines, the scientific community will be equipped with tools that can enhance the identification of novel therapeutic avenues and improve patient outcomes.
Our company specializes in providing top-tier biological products backed by cutting-edge technology and expertise in genetic engineering. With a commitment to quality and innovation, we are dedicated to supporting your research and clinical endeavors in the life sciences.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.